News
Displaying 181–190 of 504
-
RD Fund Launches Opus Genetics to Advance Gene Therapies for Inherited Retinal Diseases
Research NewsFirst two programs are for Leber congenital amaurosis: LCA5-lebercillin and LCA13-RDH12
-
Foundation Awarded 21 New Grants in FY2021 Totaling More than $14.2 Million
Research NewsCurrent research portfolio is comprised of nearly 100 projects at prominent institutions around the world
-
MeiraGTx and Janssen Recruiting for Phase 3 XLRP Gene Therapy Clinical Trial
Research NewsVisit www.LUMEOSstudy.com for more information about trial
-
In the Press
Initial programs will focus on treatments for rare pediatric blinding conditions. Company formed to advance the work of scientific cofounders Dr. Jean Bennett, Junwei Sun and Dr. Eric Pierce.
-
Foundation News
Course Title: A Review and Comparison of Different Forms of Age-Related and Inherited Macular Degenerations
-
Apellis to Seek FDA Approval of its Dry AMD Drug
Research NewsKnown as APL-2, the drug met its primary endpoint in the OAKS clinical trial but not the DERBY trial
-
Optogenetics: Hope for Vision Restoration for Advanced Retinal Diseases
Research NewsEarly, encouraging results from two human studies — trials launched by Bionic Sight and GenSight — are putting optogenetic therapies in the spotlight for patients with advanced vision loss from retinal conditions.
-
Foundation News
This September 16th celebratory episode features the world premiere of “Dis Education” – an original collaboration by Lachi and Apl.de.Ap.
-
Pediatric Ophthalmologists Target Inherited Retinal Diseases
In the PressNew opportunities continue to develop in an evolving landscape.
-
Statement from Ben Yerxa, PhD, about Paralympian Becca Meyers
Foundation NewsThe Foundation believes that all people with disabilities should receive the accommodations necessary for their inclusion in all facets of society, especially when an individual may be unfamiliar with the area.
.png)
